The 20 Best Agranulocytosis Doctors Near Me in Pittsburgh, PA

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rossetti is board certified in American Board Of Internal Medicine. Dr. Rossetti is currently accepting new patients.

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sehgal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sehgal is currently accepting new patients.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC.Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Gamma Knife Radiosurgery. Dr. Gorantla is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Gorantla is currently accepting new patients.

Monica Khunger Malhotra, MD is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Malhotra is trained in the management of all cancers and blood disorders with a focus in gastrointestinal, breast and thoracic malignancies. Dr. Malhotra is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and Bone Tumor. Dr. Malhotra is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Malhotra is currently accepting new patients.

Priya Rastogi, MD, is currently Associate Professor of Medicine at the University of Pittsburgh School of Medicine.Dr. Rastogi received a Bachelor of Arts degree in Chemistry from Miami University at Oxford, Ohio. She earned her MD at Wright State University School of Medicine in Dayton, Ohio and completed her residency in Internal Medicine at Saint Joseph's Hospital in Denver, Colorado, where she received the Resident of the Year Award. Her Fellowship was completed at the University of Pittsburgh School of Medicine in Pittsburgh, PA. During her fellowship, Dr. Rastogi's research was focused on Herceptin-induced cardiotoxicity, and she was awarded a grant from the National Surgical Breast and Bowel Project.Dr. Rastogi is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. She is an associate member of the American Society of Clinical Oncology and the American Association for Cancer Research. She has several abstracts and research articles in leading journals, including Seminars in Breast Disease, Oncology, and Diseases of the Breast. Dr. Rastogi practices in the Womens Cancer Center at Magee-Womens Hospital will see over 125 new breast cancer consultations and over 1250 patient visits in 2004.Dr. Rastogi has participated in the Introduction to Being a Physician course for first year medical students at the University of Pittsburgh School of Medicine for two years and is also active within the community for lectures and presentations. Dr. Rastogi is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Inflammatory Breast Cancer. Dr. Rastogi is board certified in American Board Of Internal Medicine. Dr. Rastogi is currently accepting new patients.

Julia Foldi is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. She has been practicing medicine for over 10 years. Dr. Foldi is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, and Agranulocytosis. Dr. Foldi is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Foldi is currently accepting new patients.

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia.Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee.Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, Porphyria, and Venous Thromboembolism (VTE). Dr. Smith is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Smith is currently accepting new patients.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Hou is board certified in American Board Of Internal Medicine. Dr. Hou is currently accepting new patients.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dorritie is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Dorritie is currently accepting new patients.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy. Dr. Rhee is board certified in American Board Of Internal Medicine. Dr. Rhee is currently accepting new patients.

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.

Robert Redner is a Hematologist Oncology provider practicing medicine in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Redner is currently accepting new patients.

Zahra Rahman Kelly, DO, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Kelly is trained in the management of all cancers and blood disorders with a focus in genitourinary and head and neck malignancies. Dr. Kelly is board-certified in nternal medicine and medical oncology and hematology. She received her medical degree from Philadelphia College of Osteopathic Medicine. Dr. Kelly completed both a residency in internal medicine and a fellowship in hematology/oncology at UPMC. She served as chief fellow during her final year of hematology/oncology fellowship.Her research interests include early phase clinical trial design and cancer immunotherapy combination trials. She has published papers in peer reviewed journals and is an active member of the UPMC Hillman protocol review committee where she reviews therapeutic oncology trials. She also collaborates with surgical oncologists and radiation oncologists to provide multidisciplinary care to her patients.Dr. Kelly is a member of the European Society of Medical Oncology, American Society of Medical Oncology, American Medical Association, and American Society of Hematology. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Febrile Neutropenia, Chronic Familial Neutropenia, and Gamma Knife Radiosurgery. Dr. Kelly is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kelly is currently accepting new patients.

Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Im is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Im is currently accepting new patients.

Donald Woytowitz, Jr., MD, is a hematologist/oncologist at UPMC Hillman Cancer Center. He specializes in myeloproliferative disorders, myelodysplastic syndromes, benign hematology, and non-Hodgkin lymphoma. Dr. Woytowitz is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. His clinical expertise encompasses Polycythemia Vera, Thrombocytopenia, Essential Thrombocythemia, and Schnitzler Syndrome. Dr. Woytowitz is board certified in American Board Of Internal Medicine. Dr. Woytowitz is currently accepting new patients.

Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ross is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Yvonne Chao, MD, PhD, specializes in hematology oncology and is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Magee-Womens Hospital, UPMC Presbyterian and UPMC Shadyside. She completed her medical degree and residency at the University of Pittsburgh School of Medicine, along with a fellowship at the University of North Carolina at Chapel Hill. Dr. Chao is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Large-Cell Lung Carcinoma. Dr. Chao is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy. Dr. Mullin is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.